Bioactive products from singlet oxygen photooxygenation of cannabinoids

European Journal of Medicinal Chemistry
2018.0

Abstract

Photooxygenation of Δ8 tetrahydrocannabinol (Δ8-THC), Δ9 tetrahydrocannabinol (Δ9-THC), Δ9 tetrahydrocannabinolic acid (Δ9-THCA) and some derivatives (acetate, tosylate and methyl ether) yielded 24 oxygenated derivatives, 18 of which were new and 6 were previously reported, including allyl alcohols, ethers, quinones, hydroperoxides, and epoxides. Testing these compounds for their modulatory effect on cannabinoid receptors CB1 and CB2 led to the identification of 7 and 21 as CB1 partial agonists with Ki values of 0.043 μM and 0.048 μM, respectively and 23 as a cannabinoid with high binding affinity for CB2 with Ki value of 0.0095 μM, but much less affinity towards CB1 (Ki 0.467 μM). The synthesized compounds showed cytotoxic activity against cancer cell lines (SK-MEL, KB, BT-549, and SK-OV-3) with IC50 values ranging from 4.2 to 8.5 μg/mL. Several of those compounds showed antimicrobial, antimalarial and antileishmanial activities, with compound 14 being the most potent against various pathogens.

Knowledge Graph

Similar Paper

Bioactive products from singlet oxygen photooxygenation of cannabinoids
European Journal of Medicinal Chemistry 2018.0
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency<i>Cannabis sativa</i>
Journal of Natural Products 2015.0
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor
European Journal of Medicinal Chemistry 2016.0
One-pot heterogeneous synthesis of Δ3-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB1 and CB2 receptors
European Journal of Medicinal Chemistry 2014.0
Biologically Active Cannabinoids from High-Potency <i>Cannabis sativa</i>
Journal of Natural Products 2009.0
Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors
Bioorganic &amp; Medicinal Chemistry 2007.0
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB<sub>2</sub>Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists
Journal of Medicinal Chemistry 2012.0
Cannabinoid Ester Constituents from High-Potency<i>Cannabis sativa</i>
Journal of Natural Products 2008.0
Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB<sub>2</sub>Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling
Journal of Medicinal Chemistry 2006.0
Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping
European Journal of Medicinal Chemistry 2018.0